Brief: Infant Bacterial Therapeutics H2 operating loss widens to SEK 22.0 mln
Feb 14 (Reuters) - Infant Bacterial Therapeutics Ab
IBTb.ST :
* H2 operating loss 22.0 million Swedish crowns ($2.47
million) versus loss 10.9 million crowns year ago
Source text for Eikon: ID:nGNE6HkNty
Further company coverage: IBTb.ST
($1 = 8.9210 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln